Lisanti Capital Growth LLC purchased a new position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 317,345 shares of the company's stock, valued at approximately $4,659,000. Lisanti Capital Growth LLC owned approximately 0.19% of BrightSpring Health Services at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Silvercrest Asset Management Group LLC bought a new position in shares of BrightSpring Health Services during the 1st quarter valued at $14,179,000. Price T Rowe Associates Inc. MD bought a new position in BrightSpring Health Services in the 1st quarter valued at approximately $16,260,000. TD Asset Management Inc purchased a new position in shares of BrightSpring Health Services in the 2nd quarter worth $2,308,000. Magnetar Financial LLC increased its holdings in BrightSpring Health Services by 46.9% during the second quarter. Magnetar Financial LLC now owns 1,188,302 shares of the company's stock valued at $13,499,000 after buying an additional 379,149 shares during the last quarter. Finally, Assenagon Asset Management S.A. purchased a new position in shares of BrightSpring Health Services during the 3rd quarter valued at about $1,822,000.
BrightSpring Health Services Stock Up 3.0 %
NASDAQ BTSG traded up $0.58 during trading on Monday, reaching $20.15. 1,164,780 shares of the company's stock were exchanged, compared to its average volume of 1,496,413. The company has a 50 day moving average price of $15.13 and a two-hundred day moving average price of $12.74. The stock has a market cap of $3.51 billion and a P/E ratio of -76.92. BrightSpring Health Services, Inc. has a 1 year low of $7.85 and a 1 year high of $20.15. The company has a debt-to-equity ratio of 1.63, a quick ratio of 1.00 and a current ratio of 1.35.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.07). The firm had revenue of $2.91 billion for the quarter, compared to analysts' expectations of $2.72 billion. BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The firm's revenue for the quarter was up 28.8% compared to the same quarter last year. On average, equities research analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.
Insider Activity at BrightSpring Health Services
In other BrightSpring Health Services news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of BrightSpring Health Services stock in a transaction dated Wednesday, September 11th. The stock was acquired at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the acquisition, the insider now directly owns 92,959,984 shares of the company's stock, valued at $1,034,644,621.92. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. The Goldman Sachs Group reduced their price target on shares of BrightSpring Health Services from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday, August 9th. BTIG Research increased their price objective on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a "buy" rating in a research report on Thursday, October 3rd. Guggenheim boosted their price objective on BrightSpring Health Services from $15.00 to $18.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. KeyCorp began coverage on BrightSpring Health Services in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Finally, Mizuho boosted their price objective on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an "outperform" rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $16.79.
Read Our Latest Research Report on BrightSpring Health Services
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Read More
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
